One person using Mounjaro revealed they had a peculiar ‘magic mushroom’ sensation when starting the medication in a discussion about side effects on Reddit ...

Some users of weight loss jabs have reported losing more than just the pounds-they've taken to online forums in their ...

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Once users stop taking Mounjaro, their appetite is no longer suppressed, and there's a decent chance that they will revert back to old eating habits and put the weight back on, but there are also ...

Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

The drug coverage provision does not mention any specific drug by name, but it could include the GLP-1 agonists, such as ...

The weight-loss drug boom has dominated headlines for the last two years — but underneath the hype lies a major flaw in the ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Women across the nation have connected online over their unexpected pregnancies, known as "Ozempic babies," while using GLP-1 ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?